XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Total Palantir’s Stockholders’ Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss), Net
Accumulated Deficit
AOCI Attributable to Noncontrolling Interest
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2023     2,200,128,000          
Beginning balance at Dec. 31, 2023 $ 3,560,965 $ 3,475,561 $ 2,200 $ 9,122,173 $ 801 $ (5,649,613)   $ 85,404
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares)     44,188,000          
Issuance of common stock from the exercise of stock options 270,207 270,207 $ 45 270,162        
Issuance of common stock upon vesting of restricted stock units ("RSUs") and performance-based RSUs ("P-RSUs") (in shares)     27,273,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 27 (27)        
Repurchases of common stock (in shares)     (1,780,000)          
Repurchases of common stock (45,598) (45,598) $ (2) (45,596)        
Stock-based compensation 410,668 410,668   410,668        
Other comprehensive income 4,138 4,124     4,124      
Other comprehensive income             $ 14  
Net income 390,982 383,181       383,181   7,801
Ending balance (in shares) at Sep. 30, 2024     2,269,809,000          
Ending balance at Sep. 30, 2024 4,591,362 4,498,143 $ 2,270 9,757,380 4,925 (5,266,432)   93,219
Beginning balance (in shares) at Jun. 30, 2024     2,237,939,000          
Beginning balance at Jun. 30, 2024 4,137,806 4,050,524 $ 2,238 9,463,178 (4,935) (5,409,957)   87,282
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares)     23,312,000          
Issuance of common stock from the exercise of stock options 170,337 170,337 $ 24 170,313        
Issuance of common stock upon vesting of restricted stock units ("RSUs") and performance-based RSUs ("P-RSUs") (in shares)     9,183,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 9 (9)        
Repurchases of common stock (in shares)     (625,000)          
Repurchases of common stock (18,899) (18,899) $ (1) (18,898)        
Stock-based compensation 142,796 142,796   142,796        
Other comprehensive income 9,981 9,860     9,860      
Other comprehensive income             $ 121  
Net income 149,341 143,525       143,525   5,816
Ending balance (in shares) at Sep. 30, 2024     2,269,809,000          
Ending balance at Sep. 30, 2024 $ 4,591,362 4,498,143 $ 2,270 9,757,380 4,925 (5,266,432)   93,219
Beginning balance (in shares) at Dec. 31, 2024 2,338,795,000   2,338,795,000          
Beginning balance at Dec. 31, 2024 $ 5,094,407 5,003,275 $ 2,339 10,193,970 (5,611) (5,187,423)   91,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares) 23,992,000   23,992,000          
Issuance of common stock from the exercise of stock options $ 120,839 120,839 $ 23 120,816        
Issuance of common stock upon vesting of restricted stock units ("RSUs") and performance-based RSUs ("P-RSUs") (in shares)     21,022,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 21 (21)        
Repurchases of common stock (in shares)     (495,000)          
Repurchases of common stock (55,789) (55,789)   (55,789)        
Stock-based compensation 488,627 488,627   488,627        
Other comprehensive income 17,148 17,148     17,148      
Net income $ 1,023,037 1,016,357       1,016,357   6,680
Ending balance (in shares) at Sep. 30, 2025 2,383,314,000   2,383,314,000          
Ending balance at Sep. 30, 2025 $ 6,688,269 6,590,457 $ 2,383 10,747,603 11,537 (4,171,066)   97,812
Beginning balance (in shares) at Jun. 30, 2025     2,371,847,000          
Beginning balance at Jun. 30, 2025 6,025,564 5,928,901 $ 2,372 10,568,473 4,721 (4,646,665)   96,663
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock from the exercise of stock options (in shares)     4,890,000          
Issuance of common stock from the exercise of stock options 25,638 25,638 $ 4 25,634        
Issuance of common stock upon vesting of restricted stock units ("RSUs") and performance-based RSUs ("P-RSUs") (in shares)     6,697,000          
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 7 (7)        
Repurchases of common stock (in shares)     (120,000)          
Repurchases of common stock (19,195) (19,195)   (19,195)        
Stock-based compensation 172,698 172,698   172,698        
Other comprehensive income 6,816 6,816     6,816      
Net income $ 476,748 475,599       475,599   1,149
Ending balance (in shares) at Sep. 30, 2025 2,383,314,000   2,383,314,000          
Ending balance at Sep. 30, 2025 $ 6,688,269 $ 6,590,457 $ 2,383 $ 10,747,603 $ 11,537 $ (4,171,066)   $ 97,812